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INTERAKSI HERBA-DRUG: KESAN TINOSPORA CRISPA MIERS. TERHADAP 
METABOLISME DRUG DALAM TIKUS HATI 
ABSTRAK 
Tinospora crispa Miers. (Famili: Menispermaceae) atau dikenali dengan nama 
tempatan sebagai Patawali atau Akar Sekuntum, adalah tumbuhan yang 
digunakan secara tradisional sebagai ubat untuk merawat kencing manis dan 
gangguan metabolik. Objektif kajian ini ialah untuk mengkaji kesan in vitro dan ex 
vivo ekstrak kasar dan ekstrak pelbagai pelarut daripada batang Tinospora crispa 
ke atas aktiviti aminopirin N-demetilase di dalam tikus Sprague-Oawley (SO). 
Ekstrak-ekstrak n-heksana, kloroform, n-butanol dan akues yang diperolehi 
daripada residue larutan-metanol Tinospora crispa telah digunakan untuk mengkaji 
kesan mereka ke atas metabolisme fasa I aminopirin dalam hepatosit tikus. 
Pengasingan hepatosit telah disediakan dengan menggunakan teknik perfusi 
kolagenase dan pengemparan berperingkat. Pengaruh jantina, umur dan keadaan 
penyakit (diabetes) juga telah diuji dalam kesan Tinospora crispa ke atas aktiviti 
aminopirin N-demetilase. Keputusan menunjukkan ekstrak kloroform Tinospora 
crispa, secara in vitro, boleh mempengaruhi N-demetilase aminopirin (dan 
kemungkinan ubat-ubat lain yang melalui tindakbalas fasa I N-demetilase yang 
sama, contohnya diazepam, morfin dan lain-lain). Kajian ex vivo ke atas tikus SO 
normal dan diabetik (aruhan-STZ) telah menunjukkan kes~n signifikan ke atas 
aktiviti aminopirin N-demetilase dalam tikus betina muda dan tua (kumpulan 
normal dan diabetik). Kesan ketoksikan yang mungkin diakibatkan oleh Tinospora 
crispa ke atas hati dan ginjal dalam tikus SO juga telah diuji. Keputusan diperolehi 
daripada tikus SO normal menunjukkan bahawa langkah berhati-hati perlu diambil 
XIX 
r 
i 
apabila mengambil dos 500 mg/kg dan ke atas ekstrak kloroform T. crispa secara 
jangka panjang kerana ia mungkin mengakibatkan ketoksikan ke atas hati. Walau 
bagaimanapun, dalam tikus SO diabetik (aruhan-STZ) tiada perubahan signifikan 
dalam anal isis biokimia klinikal dilihat pad a 1 0 dan 100 mglkg ekstrak kloroform 
T. crispa. Berat badan yang diperolehi dalam kajian ini menunjukkan keputusan 
berbeza dan kesan antara kumpulan dipengaruhi oleh faktor yang berbeza 
contohnya jantina, umur dan keadaan penyakit. Sejumlah 6 kematian telah 
dilaporkan dalam beberapa kumpulan yang diberi 500 mglkg ekstrak kloroform 
T. crispa. Mekanisme tindakan yang memberikan kesan in vitro ekstrak kloroform 
T. crispa ke atas metabolisme aminopirin dalam hepatosit tikus jantan muda 
diabetik mungkin diperantarakan melalui beberapa lintasan molekul i.e. lintasan 
cAMP pada kepekatan rendah; bertindak sebagai perangsang fosfatase dan 
perencat protein kinase C. Keputusan yang diperolehi dalam kehadiran furafylline 
juga mencadangkan bahawa ekstrak kloroform daripada T. crispa telah 
meningkatkan aktiviti sitokrom P4501A2· Kesimpulannya, ekstrak kloroform 
T. crispa telah mempengaruhi fasa I aminopirin N-demetilase dalam kumpulan 
yang tertentu dalam hati tikus. Penggunaan ekstrak kloroform T. crispa pada dos 
500 mg/kg dan ke atas perlu diberi perhatian sekiranya ia diambil secara jangka 
panjang kerana ia mempamerkan kesan signifikan ke atas paras AL T (alanine 
aminotransferase) dalam kumpulan tikus dewasa jantan normal. 
XX 
HERB-DRUG INTERACTION: THE EFFECT OF TINOSPORA CR/SPA MIERS. 
ON DRUG METABOLISM IN RAT LIVER 
ABSTRACT 
Tinospora crispa Miers. (Family: Menispermaceae) or locally known as Patawali or 
Akar Seruntum, is a plant that has been used locally as a remedy for diabetes 
mellitus, and metabolic disorders. The objective of this study is to investigate the in 
vitro and ex vivo effects of the crude extract and different solvent extracts of the 
stem of Tinospora crispa on aminopyrine N-demethylase activity in Sprague-
Oawley (SO) rat liver. n-Hexane, chloroform, n-butanol and aqueous extracts 
derived from methanolic-soluble residue of Tinospora crispa were used to 
investigate their effects on aminopyrine Phase I metabolism in rat hepatocytes. 
Isolated hepatocytes from SO rat liver were prepared using the collagenase 
perfusion technique and differential centrifugation technique. The influence of 
gender, age and disease (diabetes) were examined on the effects of Tinospora 
crispa on aminoyrine N-demethylase activity. Results obtained showed that the 
chloroform extract of Tinospora crispa, in vitro, could affect the N-demethylation of 
aminopyrine (and probably other drugs that undergo similar Phase I 
N-demethylation reaction such as diazepam, morphine and etc). The ex vivo study 
of normal and diabetic (STZ-induced) SO rats demonstrated that in young female & 
old female (for both normal & diabetic groups) there was a significant effect on 
aminopyrine N-demethylase activity. The possible toxic effect of the chloroform 
extract of T. crispa in liver and kidney of SO rats was determined. The results in 
normal SO rats showed that caution should be exercised for long term intake at 
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doses 500 mg/kg and more of the chloroform extract of T. crispa because it may 
cause toxicity to the liver. However, in diabetic (STZ-induced) SO rats, no 
significant change in the clinical biochemistry analysis was observed at 1 0 and 100 
mg/kg of chloroform extract of T. crispa. The body weights of the rats were variable 
between the groups, depending on different factors, such as gender, age & 
disease condition. A total of 6 deaths were reported in several groups which were 
administered with 500 mg/kg of the chloroform extract of T. crispa. The in vitro 
effect of the chloroform extract of T. crispa on aminopyrine metabolism in young 
male diabetic rat hepatocytes was probably mediated through various molecular 
pathways i.e. via the cAMP pathway at lower concentrations; as a phosphatase 
stimulant and an inhibitor of protein kinase C. In the presence of furafylline, the 
chloroform extract of T. crispa enhanced the activity of cytochrome P4501A2· In 
conclusion, the chloroform extract of T. crispa affected Phase I aminopyrine 
N-demethylation in certain groups of rat liver. Caution must be exercised when 
using the chloroform extract of T. crispa at doses equal to or greater than 500 
mg/kg for the long-term because it significantly elevated the Al T (alanine 
aminotransferase) level in adult male rats. 
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CHAPTER 1: INTRODUCTION 
1.1 Herb-Drug Interactions 
Nowadays, people are aware of the herb-drug interaction, especially for those 
patients on co-morbidity medication. Herb-drug interaction is a hot topic of 
debate because many herbs have not been studies or reported. The concerns 
are multiplied for those patients currently taking multiple medications, often 
prescribed by multiple physicians who may or may not be in communication 
with each other regarding their patient's medication history (Subhuti, 2000). 
Non-error, adverse effects of medications account for the fourth leading cause 
of death in the United States at 106,000 deaths per year (Starfield, 2000; 
Castleman, 1998; Subhuti, 2000), while annual deaths from herbs until 2002 
were only a handful nationwide (Duke, 1985; 2001 TESS Annual Report, 2002). 
The increased use of herbal medicines has resulted in increased concern about 
the efficacy and the safety of these products. Indeed, there has been a number 
of reports of toxic effects from traditional and herbal medicines - the WHO 
database currently lists 8985 adverse drug reaction reports in which herbal 
preparations are suspected of being implicated (Global standardization for 
herbal medicines, 1998). It is important for herbalists, pharmacists and 
physicians to understand the nature of herb-drug interactions, and to defend 
their profession and their products from unjustified attack. 
Many whole herbs have remained in the pharmacopoeias of nations that now 
rely on modem medicine, but the difficulties in procuring and handling the high-
quality herbal materials has led to replacements by isolates and synthetics 
(Subhuti, 1998). Within the context of using intensively regulated, pure chemical 
drugs, medical doctors have correctly raised questions about the identity and 
variability of herbs that have been provided as alternatives without adequate 
clinical testing and without monitoring of adverse effects once on the market 
On the other hand, herbs (as well as other natural healing approaches) were 
sometimes dismissed under the incorrect premise that modern medicine had 
already provided a satisfactory replacement for all the earlier health care 
practices that had been relied upon for centuries (Subhuti, 1998). 
Herbs have been in demand for the past few years. Normally herbs served in the 
market are in the form of beverage teas which can produce a good taste, and 
typically provided in convenient tea bags. However, as the demand of herbs 
grew, some medicinal herbs have been sold in the form of capsules and tablets 
which often containing standardized extracts or specified levels of one active 
ingredient. More people then turned to herbs in these dosage forms as an 
alternative to pharmaceutical drugs (e.g. take echinacea instead of an antibiotic; 
St John's wort instead of an antidepressant) (Subhuti, 2000). However, as the 
use of drugs has increased dramatically in recent years, especially among the 
elderly, herbs have also been increasingly used with other drugs rather than in 
place of drugs, raising the concern about the interaction of herbs and drugs. 
From the perspective of the modern medical profession, if an herb or herbal 
mixture can have a therapeutic activity that is comparable to that of a drug, it can 
also interact with other drugs (Leake, 1975; Sionneau, 1995; Subhuti, 2000). 
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Herbs were a dominant medical therapy in the Chinese culture during the 20th 
century, and pharmaceutical drugs were a relatively recent addition to their 
medical field (Subhuti, 1998). But, it is in a different situation in the western 
countries. Herbs had been almost entirely replaced by drugs during the 20th 
century, and were later reintroduced once drugs had become a dominant 
feature of modern health care. In the west, the replacement of herbs by drugs 
took place over a period of many decades during which there was a prevailing_ 
attitude that drugs were more reliable than herbs. The re-introduction of herbs 
brings with it suspicions and concerns about their unreliability and the lack of 
adequate knowledge about them (Subhuti, 1998). The herbs listed in table 1.1 
are used in the Chinese tradition. Warfarin is the drug most often suggested to 
have interactions with other herbs (Subhuti, 1998; Subhuti, 2000). 
Nowadays, doctors and pharmacists are provided with courses and educational 
materials which outline the potential problems associated herbs, with the need 
of herb-drug interaction. There is a considerable amount of speculation about 
herb-drug interaction, based on knowledge which is also quite limited pertaining 
to drug-drug interactions and food-drug interactions. 
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1.1.1 Concepts of Herb-Drug Interactions (Definition) 
A basic problem is that the phrase "herb-drug interaction" routinely appears in 
the media, without definition and an assumption that everyone knows what it 
meant. There are several distinct categories of interactions defined in 
pharmacology texts. The basic concept of interaction is that consumption of two 
or more substances, either herbs, drugs, foods, or liquids at the same time, or 
within a short time of each other, will result in physiological effects that are 
different from a simple summation of the effects of either taken separately, 
which is the basic definition of a non-linear effect. The vast majority of so-called 
"interactions· is probably not interactions at all and is simple linear effects, but 
result from individual users' ignorance of the total known clinical effects of a 
substance, published in standard clinical materia medica. Besides, relatively 
less common type of interaction is a pharmaceutical interaction in which the two 
substances interact by direct chemical action with each other, either before 
ingestion, or while mixed together in the stomach and intestines (Roger, 2004). 
The nature of herb-drug interactions is not a chemical interaction between a 
drug and an herb component to produce something toxic (Subhuti, 2000). 
Instead, the interaction may involve having an herb component cause either an 
increase or decrease in the amount of drug in the blood stream. A decrease in 
the amount of drug could occur by herb components binding up the drug and 
preventing it from getting into the blood stream from the gastrointestinal tract, or 
by stimulating the production and activity of enzymes that degrade the drug and 
prepare it for elimination from the body. An increase in the drug dosage could 
occur when an herb component aids absorption of the drug, or inhibits the 
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enzymes that break down the drug and prepare it for elimination. A decrease in 
drug dosage by virtue of an interaction could make the drug ineffective; an 
increase in drug dosage could make it reach levels that produce side effects. 
Alternatively, an herb might produce an effect that is contrary to the effect 
desired for the drug, thereby reducing the drug effect; or, an herb might produce 
the same kind of effect as the drug and give an increase in the drug effect 
(without increasing the amount of the drug) (Subhuti, 2000). 
Examples of concerns about herb-drug interactions that have been raised 
(Subhuti, 2000) are that an herb might: 
• increase or decrease the effect of a blood thinner such as warfarin and 
lead to either a bleeding episode or formation of a dangerous clot; 
• decrease the effect of a blood pressure medication, leading to high blood 
pressure and a stroke; 
• decrease the effect of an anti-infective agent, letting the infection get out 
of control; or 
• increase the effect of an anti-diabetics drug and plunge blood sugar to 
dangerously low levels. 
Such responses can occur with drug-drug interactions and with food-drug 
interactions, so the finding of some instances of herb-drug interaction would not 
be surprising (Refer to Table 1.2). 
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Table 1.1: Some Herbs Recently Mentioned as Having Potential for Drug 
Interactions (taken from Subhuti, 2000) 
Herb Source Interactions Reported or Suspected 
Sl John's wort Hypericum perforatum warfarin (to cause bleeding); serotonin-
tianjihuang (tops) uptake inhibitors (to cause mild serotonin 
syndrome); indinavir (increased 
bioavailability); digitoxin, theophylline, 
cyclosporin, phenprocoumon, and oral 
contraceptives (all with reduced 
bioavailability) 
Ginseng Panax ginseng antidepressants such as phenelzine 
renshen (root) sulfate (to cause manic episodes, 
headaches); warfarin (to cause bleeding 
or to decrease effectiveness); 
corticosteroids (potentiation); estrogens 
(potentiation) 
Ginkgo Ginkgo biloba warfarin (to cause bleeding) 
yinxingye (leaf) 
Ginger Zingiber officinale sulfaguanidine (enhance absorption) 
jiang (rhizome) 
Garlic Allium sativum warfarin (to cause bleeding) 
dasuan (bulb) 
Tang-kuei Angelica sinensis warfarin (to cause bleeding) 
danggui (root) 
Salvia Salvia miltiorrhiza warfarin (to cause bleeding) 
danshen (root) 
Rhubarb Rheum officinale cardiac glycosides and antiarrhythmic 
dahuang (root) agents (potentiating by reducing 
potassium via laxative effect) 
Aloe Aloeferox cardiac glycosides and antiarrhythmic 
luhui (leaf sap) agents (potentiating by reducing 
potassium via laxative effect) 
Ma-huang Ephedra sinica MAO (monoamine oxidase) inhibitors (to 
mahuang (leaf) cause hypertension); cardiac glycosides 
or halothane (to produce cardiac 
arrhythmia); caffeine (to intensify 
cardiovascular side effects) 
Astragalus Astragalus cyclosporine, azathioprine, methotrexate 
huangqi membranaceus (to impair intended immuno-suppressive 
(root) effects). 
Bupleurum Bupleurum falcatum sedatives (potentiation) 
chalhu (root) 
licorice Glycyrrhiza ura/ensis corticosteroids and thiazide diuretics 
gancao (root) (potentiation); digitarts or other cardiac 
glycosides (increased sensitivity) 
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Table 1.2: Chinese Herbal Concept of Interaction of Drugs 
The common term used for interaction is xiang, literally, mutual or reciprocal 
action (that is, the drugs act upon one another) (taken from Subhuti, 2000) 
Type of Interaction Examples 
Xiangfan (incompatibility): yields toxic Raw aconite is incompatible with raw 
reaction or side effects. pinellia; licorice is incompatible with 
sargassum; veratrum is incompatible 
with scrophularia. 
Xiangwu (antagonism): reducing the Raphanus inhibits the action of 
desired effect of one drug by ginseng; ginseng inhibits the action of 
combining with another drug. pteropus; clove inhibits the action of 
curcuma. 
Xiangsha (detoxification) or Xiangwei Fresh ginger and alum each reduce 
(inhibition): one drug reduces the the toxicity of pinellia and arisaema. 
toxicity or side effects of another. 
Xiangshi (enhancement): one drug An herb that tonifies the spleen, when 
enhances the effect of the other. combined with an herb that is diuretic 
will enhance the diuretic action. 
Xiangxu (synergism): drugs of similar Rhubarb and mirabilitum are each 
nature reinforce each other's effects. purgatives that produce a more reliable 
and stronger purgative action when 
used together. 
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1.1.2 Current Issues - Synergies and Antagonisms 
It has been observed by some herbalists and phytochemists that, in many 
cases, the presumed "active" ingredients of an herb, when extracted and 
isolated, do not have quite the same pharmacological effects as the whole plant 
preparation (Roger, 2000). That this is a common experience is often plausibly 
explained as the result of complex chemical synergies within the whole herb 
preparation. Complexity in the number and type of chemical constituents may. 
merely mean that the net effect of all together may be difficult to predict, and 
part of this difficulty may or may not be due to true synergies, or non-linear 
interactions between constituents (Subhuti, 2000). Perhaps the most convincing 
evidence of phytochemical synergies within a given plant species is discussed 
by Duke (1998). He points out various examples of pairs of chemical 
constituents having a measured pharmacological effect different from that 
expected from each constituent administered individually and discusses the 
theory that plants have evolved to make the most efficient use of their 
biochemical machinery. If clusters of closely related or complementary chemical 
constituents create adaptive synergistic effects, then such clusters will tend to 
be favored by evolution. If this theory is true, it weighs heavily against the 
interests of pharmaceutical companies in isolating a few active ingredients and 
then selling them to the public, if the whole raw herbs provide the advantages of 
inherent synergies of intra-species phytochemical groups (Duke, 1998). 
Even assuming that synergistic effects among clusters of phytochemicals within 
a species might be common, if the net effect of such clusters is to maximize the 
adaptive pharmacologic effects for the survival of the plant itself, it does not 
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necessarily follow that combining herbs together will result in even more 
synergies. There would not necessarily be any additional adaptive benefit for 
two plant species to evolve merely so that humans could gain synergistic effects 
when consuming them together. The only exceptions to this might be in plants 
that coexist in nature and have a symbiotic or commensal relationship. If such 
effects do exist, they are much more likely to be accidental (Subhuti, 2000). 
Herbs can have significant positive effect when used as part of a program of 
drug therapy, such as reducing the side effects as mentioned in Subhuti's 
review (1998), but the concerns being raised by doctors and patients are for the 
potential adverse responses. The interactions depicted here (Table 1.3) may 
involve foods, herbs, or nutritional and non-nutritional supplements; the 
information stated in terms of herbs should be applied to any substance with a 
potential for drug interactions. 
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Table 1.3: Information for Practitioners to Relay to Patients about Interactions 
with Drugs (taken from Subhuti, 1998) 
Type of Interaction Examples Patient lnfonnation 
Drug absorption Tetracycline with minerals; Take herbs at least one 
inhibited by binding, alkaloids with tannins; hour apart, preferably 1.5 
resulting in low drug pectins, resins, and fibers hours apart from taking 
levels. may bind several drugs. drugs. 
Drug absorption Diarrhea or frequent bowel Treat diarrhea and avoid 
inhibited by rapid transit movements due to colitis or excessive use of laxatives. 
time, resulting in low laxative intake speeds transit Induction of diarrhea is an 
drug levels. of all materials through the intended treatment strategy 
intestinal tract. in Chinese medicine for 
nephritis. 
Drug absorption and/or Saponins may improve Take herbs at least 1.5 
elimination modified. absorption and elimination of hours apart from drugs; 
drugs, altering the blood avoid herbal preparations 
levels and rate of change of that have high saponin 
drug levels; strongly acid or content. 
alkaline herbs may alter 
absorption of drugs. 
Drugs metabolized too Grapefruit juice and herbs Take herbs at least 1.5 
slowly resulting in that inhibit CYP hours apart from drugs, 
elevated drug levels. (~ochnxne)en~e preferably taking the drugs 
system can result in much first (so that drug 
higher levels of drugs in the metabolism is already 
bloodstream, and longer under way by the time the 
persistence of the drugs. herbs can inhibit enzyme 
systems). 
Potassium decreased Laxative and diuretic herbs Avoid any strong laxative or 
when using cardiac may reduce potassium; diuretic action while using 
drugs, resulting in these types of herbs are cardiac drugs. To 
adverse cardiac often given together for compensate for mild 
conditions. weight loss. diuretic or laxative 
treatments, consume high-
potassium foods. 
Drug action is Blood vitalizing herbs and When the drug therapy is 
intensified by similar blood thinning drugs may already addressing a 
effect of herbs. prevent adequate clotting; particular therapeutic goal, 
hypoglycemic herbs and avoid adding an herbal 
hypoglycemic drugs may therapy with the same goal. 
lower blood sugar too far; Intensify monitoring of 
caffeine or ephedrine blood conditions affected by 
containing herbs and central the drugs. 
nervous system (CNS) 
stimulants disturb nerve 
functions. 
10 
1.2 Monograph of Tinospora crispa Miers. 
Tinospora crispa Miers. (Family: Menispermaceae) is a native of South-East 
Asia (Perry, 1980). The plant family Menispermaceae consists of 65 genera and 
350 species which are mainly tropical twining herbs, shrubs and trees. 
Tinospora crispa is commonly known as Glunchanb or Tinospora in English and 
Guduchi in Sanskrit. The virtues of this plant, which were long known to native 
physicians, attracted the attention of Europeans in 1827 (James & Thomas~ 
1993). In Malaysia, it is known as Patawali, Putarwali or "akar seruntum" in 
Malay (Muhamad & Mustafa, 1994); Baw-ra-pet, borapet or heart-leaved 
moonseed in Thailand (Naomichi eta/., 1983; Scott, 1998); ratnawali in Brunei; 
Makabuhai in Philipines; and K'uan Chu Hsing in Chinese (Pankaj, 2003). It is 
widely distributed throughout tropical Indian subcontinent and China, ascending 
to an altitude of 300 miles. In Hindi, the plant is commonly known as Giloe, 
Ambervel or Giloya, which is a Hindu mythological term that refers to the 
heavenly elixir that have saved celestial beings from old age and kept them 
eternally young. Through the centuries, it has been extensively used in various 
Ayurvedic preparations for the treatment of various ailments (Kirtikar & Basu, 
1933; Thatte et a/., 1987). According to the ayurvedic lexicons, T. crisps is 
referred to as ·Amrita", which means its ability to impart youthfulness, vitality 
and longevity to its patron. Thus, Tinospora species is categorized in Ayurveda 
as •Rasayana·. 
II 
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1.2.1 Taxonomy 
Division: Spermatophyta 
Sub Division: Angiosperrnae 
Class: Dicotyledonae 
Order: Ranunculales 
Family: Menisperrnaceae 
Genus: Tinospora 
Species: Tinospora crispa Miers. (Muhamad & Mustafa, 1994) 
Synonyms: Tinospora tuberculata Beumee; Tinospora rumphii Boerl. Tinospora 
cordifolia Miers.; Tinospora baenzigeri; Tinospora fragosa (Fukuda eta/., 1993; 
Teresita eta/., 1995; Cavin eta/., 1998) 
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1.2.2 Morphology 
Tinospora crispa Miers. is a climbing herb with spotted stems and about 1.0 to 
1.5 centimeters in diameter. It is usually grown in the backyards with climbing 
on other vegetation or on the fences as a medicinal plant (see Plates 1.1 & 
1.2). The young stem of the plants appears green and gradually turns to brown 
and woody when old. The characteristic feature of the plant is the surface of the 
stem which is warty. The stems shows a radiating pattern, which twine around. 
the other plants for its physical support. The bark is corky and tubercled and the 
leaf is broad cordate and acuminate with 5 to 14 centimeters long, and 3 to 10 
centimeters wide, and the leaf veins are very obviously seen. It has petiole in 3 
to 10 centimeters long and oppositely arranged. The flower is dioeciously, 
pedicellate and in pale yellow, and the main flower stalk is a long raceme. The 
female flower is isolated and has oblong-spatulate petals, small stamen, and 
carpel in three or usually less. The male flower is in small fasciles with six 
sepals, and all is in two rows; the outer row consists of short and rounded 
sepals while the sepals in the inner row is twice as long, obovate, broad, convex 
and smooth as petals and stamens (Zhari eta/., 1999). 
13 
Plate 1.1 & Plate 1.2: The stems of Tinospora crispa plant obtained from Balik Pulau, 
Penang, Malaysia. The plant has been identified and voucher specimen was deposited 
in the herbarium of the School of Pharmaceutical Sciences, Universiti Sains Malaysia, 
Penang, West Malaysia. (Picture Source: Personal) 
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1.2.3 Constituents of Tinospora crispa 
A variety of constituents have been isolated from Tinospora crispa and other 
Tinospora species, and their structures were elucidated. They belong to 
different classes such as alkaloids, diterpenoid lactones, glycosides, steroids, 
sesquiterpenoids, phenolics, aliphatic compounds and polysaccharides. The 
leaves of this plant are rich in protein (11.2 %) and are fairly rich in calcium and 
phosphorus {Khosa & Prasad, 1971). The bitter principles have been identified 
by some researchers such as columbin, a diterpenoid furanolactone 
(Swaminathan eta/., 1989a), chasmanthin and palmarin {Bhide eta/., 1941). 
1.2.3.1 Alkaloids 
The plant family Menispermaceae has long served as a rich source of alkaloids. 
Several compounds has been isolated from Tinospora species such as N-trans-
feruloyl-tyramine (1), N-cis-feruloyl-tyramine (2) (Fukuda et a/., 1983), 
N-formylannonaine (3), N-fonnylnomuciferine (4), N-acetylnomuciferine (5) (see 
Figure 1.1) {Pachaly & Adnan, 1992), palmatine, berberine, jatrorrhizine, 
tembetarine, choline (Bisset & Nwaiwu, 1983), magnoflorine (Qudrat-1-Khuda et 
a/., 1964), tinosporin, N-formyl- and N-acetyl-aporphine (Pachaly & Adnan, 
1992) isocolumbin, and tetrahydropalmatine (Sarma eta/., 1998). 
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Figure 1.1: Alkaloids isolated from Tinospora cordifolia 
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1.2.3.2 Glycosides 
The more polar n-butanol fraction from Tinospora species has produced some 
glycosides compounds. There were cordifolisides A (6), B (7), C (8) (see Figure 
1.2); norditerpene furan glycosides (Gangan eta/., 1994), cordifoliside D & E 
(Gangan et a/., 1995), syringin, syringin-apiosylglycoside, 18-norclerodane 
glucoside (Khan et a/., 1989), tinocordiside (Ghosal & Vishwakarma, 1997), 
tinocordifolioside (Maurya & Handa, 1998), cordioside (Wazir eta/., 1995), and. 
cordifolioside B (Gangan eta/., 1994; Maurya eta/., 1996). 
1.2.3.3 Diterpenoid lactones, Clerodane-derived terpenes & 
Sesquiterpenes 
Tinospora cordifo/ia has been claimed to be the species which is rich in 
derodane derived diterpenes (Pachaly & Adnan, 1992; Fukuda eta/., 1993; 
Gangan eta/., 1995; Maurya, 1996). Several new clerodane furano diterpene 
glucosides have been designated as amritosides A (9), B (10), C (11), (see 
Figure 1.3) and D (Maurya eta/., 2004). Other compounds isolated from this 
species such as tinosporaside (12), tinosporide (13) (Swaminathan eta/., 1989; 
Hanuman et a/., 1986), furanolactone (Hanuman et a/., 1988), tinocordifolin 
(Maurya & Handa, 1998), tinosponone, tinocordioside (Maurya et a/., 1995), 
(5R, 1 OR)-4R,8R-dihydroxy-2S,3R: 15, 16-diepoxycleroda-13 (Pachaly & 
Schneider, 1981),14-dieno-17, 125:18, 1S-dilactone (Swaminathan eta/., 1988), 
columbin (14) (see Figure 1.4) (Swaminathan eta/., 1989a), tinosporon (Qudrat-
1-Khuda eta/., 1966), and jateorine (Bhatt & Sabata, 1990). 
17 
RO 
Po ~--, 0 
c 0 
I 
OMe (6) Cordifolisides A 
C~"f:! /~w~ 
"lA( 
O==C 1,R 
I 
O.Me 
(8) Cordifolisides C 
Figure 1.2: Glycosides isolated from genus Tinospora 
, o:s... 
OR I 
C<>tR 
p 
./ 'o 
~CIIa~~ 
(9) Amtitoside A; 
mr·~· ! 
'"' C<>tCBanRz 
(10) Amritoside B; 
~0 
= 
.;;, 
OR I 
/~o 
COzCIIa {)Rz 
(11) Amritoside C; 
R1=H, R2=J3-D-Giucopyranosyt; Amritoside AlBIC 
R1=Ac, R2=Tetra-O-acetyi-J3-D- Glucopyranosyf; Amritoside AlBIC pentaacetate 
Figure 1.3: Clerodane furano diterpene glucosides from genus Tinospora 
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Figure 1.4: Diterpenoid lactones, Clerodane-derived terpenes & 
Sesquiterpenes isolated from genus Tinospora 
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Other species of the genus Tinospora have also been isolated and identified 
such as baenzigeride (15) and baenzigeride A (16) (see Figure 1.5) from 
T. baenzigeri (Pittaya et a/., 1999), menispermacide, cycloeuphordenol, 
malabarolide 81, and 10-a-hydroxycolumbin from T. malabarica (Atta-Ur-
Rahman et a/., 1988; Atta-Ur-Rahman et a/., 1992), rumphioside A - F, 
rumphioside I, and tinoporicide from T. rumphii (Teresita eta/., 1995; Atta-Ur-
Rahman et a/., 1991), tinocrisposide, a bitter furanoditerpene glucoside 
(Pachaly & Adnan, 1992), cycloeucalenol (17) and cycloeucalenone (18) (see 
Figure 1.6) from T. crispa (Ngampong eta/., 2002). 
1.2.3.4 Steroids 
~ - Sitosterol, o-sitosterol, 2~hydroxy ecdysone, ecdysterone, makisterone A, 
and giloinsterol were six steroids isolated by Pathak eta/. (1995), Khaleque et 
a/. (1970), Kidwai eta/. (1949), Pradhan eta/. (1997), and Gangan eta/. (1997). 
However, no further work was carried out to determine their bioactivities. 
1.2.3.5 Aliphatic compounds 
Three aliphatic compounds have been isolated from Tinospora species, i.e. 
octacosanol, heptacosanol and nonacosanol-15-one (Dixit & Khosa, 1971; 
Hanuman eta/., 1986; Khaleque eta/., 1970). However, no further work was 
carried out to determine their bioactivities. 
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Figure 1.5: Diterpenoid lactones, Clerodane-derived terpenes & 
Sesquiterpenes isolated from genus Tinospora 
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Cycloeucaleool 
Figure 1.6: Isolation of two triterpenes from the stems of Tinospora crispa, 
namely, cycloeucalenol (17) and cycloeucalenone (18) 
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1.2.4 Bioactive Properties of Tinospora crispa 
It has been indicated in Ayurvedic treatment as a tonic, vitalizer and as a 
remedy for diabetes and metabolic disorders (Nadkami, 1992; Chopra et a/., 
1956). All parts of the plant are used as medicine but the stem and root are 
used most frequently. According to Ayurveda, the stem is bitter, stomachic, 
tonic, appetizer, antipyretic and expectorant. It is used in the treatment of 
vomiting, fever, blood disorders, jaundice (Pelia), enlarged spleen, vaginal and 
urethral discharges, giddiness, piles, anaemia, diabetes, skin troubles and 
cough. It caught the notice of European physicians in India for its tonic and 
diuretic properties (Pendse et a/., 1977) and the drug became an official 
preparation in Indian Pharmacopoeia in 1932. Gulancho (T. crispa) was also 
included in Bengal Pharmacopoeia in 1844 and in Indian Pharmacopoeia in 
1868. Scientific reports describing anti-diabetic (Gupta et a/., 1967), 
immunomodulatory (Atal eta/., 1986), anti-hepatotoxic (Peer & Sarma, 1989), 
antipyretic (lkram eta/., 1987; Vedavathy & Rao, 1991) and anti-stress activity 
(Sarma et a/., 1995) are available. The leaves of T. crispa exhibits anti-diabetic 
action in alloxan diabetic rabbits (Noreen et a/., 1992). Some authors have 
shown that T. crispa roots possess antiulcer effect (Sarma et a/., 1995). 
Recently, Thatte and Dahanukar (1989) have shown that the aqueous extracts 
of the plant stimulated the phagOcytic and bactericidal activity of neutrophils and 
macrophages. 
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Tinospora species have been used traditionally for antitoxin action and as a 
febrifuge (Nadkarni, 1992), and also used for urinary diseases, syphilis, skin 
diseases, and bronchitis (Kapoor, 1990). Atal et at. (1986) showed that an 
ethanolic extract of Tinospora species appeared to improve the phagocytic 
activity of the reticuloendothelial system in mice. Another recent study analyzed 
six pure compounds isolated from Tinospora species for their 
immunomodulatory activity (Kapil & Sharma, 1997). The compounds syringin . 
and cordiol inhibited the in vitro immunohaemolysis of antibody-coated 
erythrocytes due to inhibition of the C3-convertase of the classical complement 
pathway. All six compounds exhibited significant enhancement of lgG 
(Immunoglobulin G) antibodies, with cordiol having the highest 
immunostimulating activity. The compounds cordioside, cordiofolioside, and 
cordiol induced a significant increase in phagocytic activity by activation of the 
peritoneal macrophages. In an animal model of cholestasis, significant 
depression of the activities of polymorphonuclear cells (PMN) and peritoneal 
macrophages was observed (Rege eta/., 1989). 
It is reported that the daily administration of either alcoholic or aqueous extract 
of T. cordifolia decreases the blood glucose level and increases glucose 
tolerance in rodents (Gupta eta/., 1967; Grover eta/., 2001). Aqueous extract 
also caused a reduction in blood sugar in alloxan induced hyperglycemia in rats 
and rabbits at a dose of 400 mglkg. However, histological examination of 
pancreas has not revealed any evidence of regeneration of P-cells of islets of 
langerhans and the possible mode of action of the plant is through glucose 
metabolism (Raghunathan & Sharma, 1969). The aqueous extract has also 
23 
exhibited some inhibitory effect on adrenaline-induced hyperglycemia. Ethyl 
acetate extract of its roots has afforded a pyrrolidine derivative with 
hypoglycemic activity in rabbits (Mahajan & Jolly, 1985; Grover et a/., 2000; 
Stanely eta/., 2000). Another study has also revealed significant hypoglycemic 
effect of the extract of leaves in normal and alloxan diabetic rabbits. However, 
the extract had no significant effect on total lipid levels in normal or treated 
rabbits (Wadood eta/., 1992; Basnet eta/., 1995). 
1.3 Drug Metabolism & Liver 
Drug metabolism or biotransformation is an integral component of the 
processes that govern the pharmacokinetic profile of therapeutically used drugs. 
Biotransformation generally converts non-polar, lipophilic pharmacologically 
active drug molecules into polar, inactive, or nontoxic metabolites that are 
readily eliminated by the kidneys or other organs. Traditionally, 
biotransformation pathways are classified into two groups: Phase I reactions 
that involve functionalization of drug substrates to yield more polar derivatives 
such as alcohols, phenols, or carboxylic acids; and Phase II reactions involving 
bimolecular conjugation with endogenous hydrophilic moieties to yield products 
such as glucuronides and sulfates that are readily excreted by kidneys 
(Venkatakrishnan eta/., 2001). 
The liver is the major site of drug metabolism, with intestinal drug extraction 
playing a secondary yet potentially important role in the pre-systemic elimination 
of orally administrated agents. The liver has long been recognized as the major 
organ for all phases of intermediary metabolism (Brauer, 1956; Brauer, 1963). 
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